USA Financial Formulas’s Encompass Health EHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-2,103
Closed -$258K 280
2025
Q2
$258K Buy
+2,103
New +$240K 0.04% 118
2025
Q1
Sell
-3,642
Closed -$336K 309
2024
Q4
$336K Buy
3,642
+240
+7% +$23.6K 0.05% 118
2024
Q3
$329K Buy
+3,402
New +$306K 0.05% 111
2019
Q1
Sell
-13,731
Closed -$852K 186
2018
Q4
$852K Buy
13,731
+8,013
+140% +$456K 0.21% 85
2018
Q3
$308K Buy
+5,718
New +$348K 0.08% 211

Other funds holding EHC

USA Financial Formulas's EHC Position: Q3 2025 in Review

USA Financial Formulas sold out of Encompass Health (EHC) in Q3 2025, closing a stake of 2,103 shares — an estimated $258K sold.

USA Financial Formulas first reported a position in EHC in Q3 2018 and held it in 5 quarters. The position peaked at $852K in Q4 2018. 604 funds tracked by Wall St. Rank hold EHC as of Q3 2025.

  • USA Financial Formulas reported no remaining Encompass Health position as of Q3 2025 after selling out during the quarter.
  • USA Financial Formulas sold 2,103 Encompass Health shares in Q3 2025, an estimated $258K.
  • USA Financial Formulas first reported a position in Encompass Health in Q3 2018 and held it in 5 quarters.
  • USA Financial Formulas's Encompass Health position peaked at $852K in Q4 2018.
  • 604 funds tracked by Wall St. Rank held Encompass Health as of Q3 2025.

Based on USA Financial Formulas's 13F filing for Q3 2025, filed 10 Oct 2025.